The global urgent care center market is predicted to register growth over the forecast period. Increasing prevalence of chronic diseases and injuries which may require emergency medical treatment are expected to propel the market growth. Cost-effective treatment is the major driver of this market owing to greater penetration to the market and increasing the affordability of emergency care. Increasing incidences of cardiovascular or sports-related injuries reduced waiting time of patients and growing awareness about urgent care center are anticipated to drive the market in coming seven years. Furthermore, an increasing number of healthcare insurance and other medical reimbursement facilities coupled with supportive government policies are expected to drive the global urgent care center market. The developing nations such as India and China are anticipated to witness lucrative growth owing to large untapped potential market and rising disposable income. Rapid innovation in technology has led to the introduction of novel therapies into the market thereby, decreasing the LOS (Length of Stay).
The global urgent care center market is segmented on the basis of service and end use. Injury, diagnostic, physical, vaccination, illness, and screening are the sub-classes of service-based urgent care center market. Injury and diagnostic segments are expected to witness significant growth over the forecast period owing to the increasing number of accidents and large scale testing of life-threatening diseases. On the basis of end use, the global urgent care center market is segmented into large scale hospitals, medium scale hospitals, and small scale hospitals. In 2014, large scale hospitals dominated the entire end use market. Due to the high budget and tie-up with both public & private sectors firms large scale hospitals segment is expected to continue its highest market share over the forecast period. Medium-scale hospitals are also expected to show significant growth by 2022 due to the rapidly declining price of urgent care center devices.
Geographically, the global urgent care center market is divided into North America, Latin America, Europe, Asia Pacific, and MEA. In 2014, North America was the dominant market region owing to an increasing number of urgent care centers. The PPAC (Patient Protection and Affordable Care) Act, 2010, covering almost 32 million individuals in the U.S. and growing medical coverage in the U.S. and Canada are anticipated to be the most vital factors for maintaining its dominance over the forecast period. Asia Pacific region is expected to show high growth in the coming seven years due to rising incidences of injuries, rising disposable income, and improving healthcare infrastructure.
Major market players are AFC/Doctors Express, FastMed Urgent Care, MedExpress, CareSpot Express Healthcare LLC, MD Now, Concentra, Inc., U.S. HealthWorks, Inc., MinuteClinic, LLC, Patient First, and NextCare. The global urgent care market is highly consolidated and competitive in nature. The present market players are adopting many new business development policies for the expansion of their business such as acquisition, mergers, and New Product Development (NPD).
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.